Vétoquinol SA Reports Sales Results for the Fourth Quarter and Full Year of 2012; Provides Operating Margin Guidance for 2012
Total 2012 sales amounted to EUR 298.3 million, up 5.0% compared to 2011. Like-for-like growth came in at 1.6%, or 3.8% after adjusting for generics competing with the Marbocyl(R) range.
The company provided operating margin guidance for 2012. 2012 operating margin excluding non-recurring items will be higher than in the previous year.